A Rollover Study of CC-122

Clinical trial NCT05688475 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05688475
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2023-04-11
Primary completion: 2026-10-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.